Botulinum Toxin Type A Injection for Neuropathic Pain in a Patient With a Brain Tumor: A Case Report
Annals of Rehabilitation Medicine
;
: 1088-1092, 2017.
Artículo
en Inglés
| WPRIM
| ID: wpr-11658
ABSTRACT
Neuropathic pain is usually managed pharmacologically, rather than with botulinum toxin type A (BTX-A). However, medications commonly fail to relieve pain effectively or have intolerable side effects. We present the case of a 62-year-old man diagnosed with an intracranial chondrosarcoma, which was removed surgically and treated with radiation therapy. He suffered from neuropathic pain despite combined pharmacological therapy with gabapentin, amitriptyline, tramadol, diazepam, and duloxetine because of adverse effects. BTX-A (100 units) was injected subcutaneously in the most painful area in the posterior left thigh. Immediately after the injection, his pain decreased significantly from 6/10 to 2/10 on a visual analogue scale. Pain relief lasted for 12 weeks. This case report describes intractable neuropathic pain caused by a brain tumor that was treated with subcutaneous BTX-A, which is a useful addition for the management of neuropathic pain related to a brain tumor.
Texto completo:
Disponible
Índice:
WPRIM (Pacífico Occidental)
Asunto principal:
Muslo
/
Tramadol
/
Toxinas Botulínicas
/
Encéfalo
/
Neoplasias Encefálicas
/
Condrosarcoma
/
Toxinas Botulínicas Tipo A
/
Diazepam
/
Clorhidrato de Duloxetina
/
Amitriptilina
Límite:
Humanos
Idioma:
Inglés
Revista:
Annals of Rehabilitation Medicine
Año:
2017
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS